Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: Potential role for early remodeling in atrial fibrillation

被引:69
|
作者
Gassanov, N
Brandt, MC
Michels, G
Lindner, M
Er, F
Hoppe, UC
机构
[1] Univ Cologne, Dept Internal Med 3, D-50937 Cologne, Germany
[2] Univ Cologne, CMMC, Ctr Mol Med, D-5000 Cologne 41, Germany
关键词
angiotensin; atrial fibrillation; ionic currents; calcium sparks; remodeling;
D O I
10.1016/j.ceca.2005.10.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Atrial angiotensin II (ANG II) levels have been shown to be increased in atrial fibrillation (AF). The purpose of the study was to evaluate a potential role of ANG II in the early remodeling and susceptibility to chronicization of AF. Methods and results: Isolated human atrial myocytes were incubated in ANG II and/or angiotensin type 1 receptor blocker candesartan. ANG II markedly increased the frequency of spontaneous Ca2+ sparks, spark full duration, time to peak Ca2+ fluorescence and decay time measured by confocal imaging. Sarcoplasmic reticulum calcium content estimated by caffeine-evoked calcium release did not differ between ANG II-treated cells and controls. Patch-clamp recordings revealed that ANG II significantly decreased I-to and increased I-Ca,I-L current densities. Candesartan blocked these ANG II-mediated alterations. ANG II exhibited no effect on I-KI, I-Kur and I-f current size. Expression of connexin 40 and connexin 43 was not significantly changed by ANG II as assessed by immunohistochemistry and Western blot analysis. Conclusion: ANG II-induced alterations of calcium handling and electrophysiological changes inhuman atrial cells similar to those previously observed in the onset of AF. Prevention of these alterations by candesartan might constitute a useful pharmacological strategy for the treatment of AF. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 50 条
  • [1] The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation
    Workman, AJ
    Kane, AK
    Rankin, AC
    CARDIOVASCULAR RESEARCH, 2001, 52 (02) : 226 - 235
  • [2] Effects of atrial fibrillation on the distribution, dimensions, and frequency of calcium sparks in human atrial myocytes
    Barriga, M.
    Llach, A.
    Lacalle, E.
    Cabello, N.
    Ballester, B.
    Vallmitjana, A.
    Munoz, C.
    Benitez, R.
    Cinca, J.
    Hove-Madsen, L.
    EUROPEAN HEART JOURNAL, 2011, 32 : 468 - 468
  • [3] Ionic Remodeling and Direct Effects of Valsartan on Ionic Currentsin Human Atrial Myocytes with Atrial Fibrillation
    薛玉梅
    吴书林
    邓春玉
    钱卫民
    陈纯波
    South China Journal of Cardiology, 2004, (02) : 63 - 70
  • [4] Prostaglandin I2 signaling prevents angiotensin II-induced atrial remodeling and vulnerability to atrial fibrillation in mice
    Zhang, Yue
    Yuan, Meng
    Cai, Wenbin
    Sun, Weiyan
    Shi, Xuelian
    Liu, Daiqi
    Song, Wenhua
    Yan, Yingqun
    Chen, Tienan
    Bao, Qiankun
    Zhang, Bangying
    Liu, Tong
    Zhu, Yi
    Zhang, Xu
    Li, Guangping
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [5] Olmesartan prevents atrial endocardial remodeling induced by atrial fibrillation: Involvement of angiotensin II
    Yamashita, T
    Sekiguchi, A
    Sagara, K
    Linuma, H
    Aizawa, T
    Fu, LT
    CIRCULATION, 2005, 112 (17) : U79 - U79
  • [6] Pioglitazone Improves Potassium Channel Remodeling Induced by Angiotensin II in Atrial Myocytes
    Gu, Jun
    Hu, Wei
    Liu, Xu
    MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2014, 20 : 153 - 160
  • [7] Isorhamnetin Reverses Angiotensin Ii-induced Atrial Fibrillation Vulnerability Through Electrophysiological and Structural Reverse Remodeling in Mice
    Aonuma, Kazuhiro
    Xu, Dong-Zhu
    Murakoshi, Nobuyuki
    Tajiri, Kazuko
    Tominaga, Kenichi
    Ieda, Masaki
    Isoda, Hiroko
    CIRCULATION, 2020, 142
  • [8] MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation
    Wang, Huibo
    Liu, Mingxin
    Wang, Xixing
    Shuai, Wei
    Fu, Hui
    EUROPACE, 2022, 24 (02): : 340 - 347
  • [9] Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling
    Zhan, Ge
    Wang, Xinying
    Wang, Xin
    Li, Jiatian
    Tang, Yuqi
    Bi, Hailian
    Yang, Xiaolei
    Xia, Yunlong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 978
  • [10] Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice
    Li, Jing
    Wang, Shuai
    Bai, Jie
    Yang, Xiao-Lei
    Zhang, Yun-Long
    Che, Yi-Lin
    Li, Hui-Hua
    Yang, Yan-Zong
    HYPERTENSION, 2018, 71 (05) : 866 - +